Clinical Trial Update: The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

This entry summarizes a Phase 2 trial evaluating the addition of ipilimumab to carboplatin and etoposide for extensive-stage small cell lung cancer, which has c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Extensive-stage Small Cell Lung Cancer
• Small Cell Lung Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Etoposide (Etoposide)
• Yervoy (ipilimumab)

Snippet

Sponsor: University Hospital Southampton NHS Foundation Trust | Conditions: Extensive Stage Small Cell Lung Cancer | Phase 2 | Status: COMPLETED